30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Eric Rowinsky

Track

Insider profile

Currently holds positions in Fortress Biotech Inc, Biophytis SA, ImClone LLC, Biogen Inc, Verastem Inc and Fortress Biotech Inc

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 7% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Co-Vice Chairman and Director Fortress Biotech Inc Dec. 31, 2015 -
Director Biophytis SA None -
Executive Vice President - Clinical Research, Chief Medical Officer ImClone LLC Dec. 1, 2007 -
Independent Director Biogen Inc March 22, 2010 -
Independent Director Verastem Inc May 3, 2017 -
Vice Chairman of the Board Fortress Biotech Inc Jan. 27, 2014 -
Chairman of the Board Navidea Biopharmaceuticals Inc Sept. 22, 2016 - March 31, 2018
Director Navidea Biopharmaceuticals Inc July 1, 2010 - Sept. 22, 2016
Vice Chairman of the Board Fortress Biotech Inc Jan. 27, 2014 - Dec. 31, 2015
Executive Vice President, Chief Medical Officer and Head of Research and Development Stemline Therapeutics Inc Nov. 1, 2011 - Oct. 27, 2015
Co-Vice Chairman of the Board Fortress Biotech Inc Oct. 1, 2010 - Jan. 27, 2014
Eric Rowinsky's trades of Biogen Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-20 2024-02-15
US Biogen Inc (BIIB)
B Purchase
22,410 -37.7%
481.02
US$4,852,685 		22,410 -37.7% 481.02 US$4,852,685
2023-02-14 2023-02-10
B Purchase
31,066 +32.1%
144.70
US$4,451,384 		31,066 +32.1% 144.70 US$4,451,384
2021-04-09 2021-03-02
S Sale
34,057 -13.4%
121.52
US$999,381 		34,057 -13.4% 121.52 US$999,381
2021-04-09 2021-02-19
S Sale
8,000 -1.1%
4.31
US$34,480 		8,000 -1.1% 4.31 US$34,480
2021-04-09 2021-02-18
S Sale
6,000 -0.8%
4.20
US$25,200 		6,000 -0.8% 4.20 US$25,200
2021-04-09 2021-02-16
S Sale
2,000 -0.3%
3.86
US$7,720 		2,000 -0.3% 3.86 US$7,720
2021-04-09 2021-02-05
S Sale
4,000 -0.5%
3.80
US$15,200 		4,000 -0.5% 3.80 US$15,200
2024-01-24 2017-09-05
US Verastem Inc (VSTM)
B Purchase
2,000 +inf%
3.84
US$7,680 		2,000 +inf% 3.84 US$7,680